LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Hyaluronan in the pathogenesis of acute and post-acute COVID-19 infection.

Barnes, Henry W / Demirdjian, Sally / Haddock, Naomi L / Kaber, Gernot / Martinez, Hunter A / Nagy, Nadine / Karmouty-Quintana, Harry / Bollyky, Paul L

Matrix biology : journal of the International Society for Matrix Biology

2023  Volume 116, Page(s) 49–66

Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged as the cause of a global pandemic. Infection with SARS-CoV-2 can result in COVID-19 with both acute and chronic disease manifestations that continue to impact many patients ... ...

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged as the cause of a global pandemic. Infection with SARS-CoV-2 can result in COVID-19 with both acute and chronic disease manifestations that continue to impact many patients long after the resolution of viral replication. There is therefore great interest in understanding the host factors that contribute to COVID-19 pathogenesis. In this review, we address the role of hyaluronan (HA), an extracellular matrix polymer with roles in inflammation and cellular metabolism, in COVID-19 and critically evaluate the hypothesis that HA promotes COVID-19 pathogenesis. We first provide a brief overview of COVID-19 infection. Then we briefly summarize the known roles of HA in airway inflammation and immunity. We then address what is known about HA and the pathogenesis of COVID-19 acute respiratory distress syndrome (COVID-19 ARDS). Next, we examine potential roles for HA in post-acute SARS-CoV-2 infection (PASC), also known as "long COVID" as well as in COVID-associated fibrosis. Finally, we discuss the potential therapeutics that target HA as a means to treat COVID-19, including the repurposed drug hymecromone (4-methylumbelliferone). We conclude that HA is a promising potential therapeutic target for the treatment of COVID-19.
MeSH term(s) Humans ; COVID-19 ; SARS-CoV-2 ; Hyaluronic Acid ; Inflammation/pathology ; Post-Acute COVID-19 Syndrome
Chemical Substances Hyaluronic Acid (9004-61-9)
Language English
Publishing date 2023-02-05
Publishing country Netherlands
Document type Journal Article ; Review ; Research Support, N.I.H., Extramural
ZDB-ID 1183793-7
ISSN 1569-1802 ; 0945-053X
ISSN (online) 1569-1802
ISSN 0945-053X
DOI 10.1016/j.matbio.2023.02.001
Shelf mark
Zs.A 1694: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top